This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Sareum Limited. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Michelle Wilson - Innovator in Kinase Inhibitors
Introduction
Michelle Wilson is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. With a total of 2 patents to her name, her work is paving the way for advancements in targeted cancer therapies.
Latest Patents
Wilson's latest patents focus on oxazole tyrosine kinase inhibitors. These inventions provide compounds that are amides of specific formulas, which include various structural components such as aryl or heteroaryl groups. The compounds are designed to inhibit kinases, specifically FLT3, FLT4, and Aurora kinases, which are crucial in cancer cell proliferation.
Career Highlights
Michelle Wilson is currently associated with Sareum Limited, a company known for its innovative drug development. Her work at Sareum has been instrumental in advancing the understanding and application of kinase inhibitors in therapeutic settings.
Collaborations
Throughout her career, Wilson has collaborated with notable colleagues, including John Charles Reader and John Mark Ellard. These partnerships have enhanced her research and contributed to the successful development of her patented compounds.
Conclusion
Michelle Wilson's contributions to the field of kinase inhibitors exemplify her dedication to innovation in medicinal chemistry. Her work continues to influence the development of targeted therapies for cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile